Literature DB >> 28578349

PTPRO Promotes Oxidized Low-Density Lipoprotein Induced Oxidative Stress and Cell Apoptosis through Toll-Like Receptor 4/Nuclear Factor κB Pathway.

Caihong Liang1,2, Xiaochen Wang3, Jianping Hu4, Xiaoqing Lian2, Tiantian Zhu2, Hui Zhang4, Ning Gu1,5, Jun Li4.   

Abstract

BACKGROUND/AIMS: Critical roles of phosphatase receptor type O (PTPRO) and toll-like receptor 4 (TLR4) have been implicated in inflammation. However, little is known about their functional effects on atherosclerosis (AS). We aim to study their potential function in AS.
METHODS: An oxidized low-density lipoprotein (ox-LDL) induced AS model constructed with PTPRO over-expressing RAW264.7 cells and PTPRO knockout macrophages. Cell apoptosis was assayed by flow cytometry and fatty accumulation was evaluated by oil red staining. The production of ROS (reactive oxygen species), SOD (superoxide dismutase), MDA (malondialdehyde), TC (Triglyceride), and TG (total cholesterol) was evaluated. Western blot was performed to detect the expression of CD36, TLR4 and nuclear factor kB (NF-κB).
RESULTS: PTPRO expression was promoted in a dose-dependent and time-dependent manner following ox-LDL challenging. In PTPRO-over-expressing cells, CD36 expression and the level of oil-red staining, TC and TG were increased; ROS production, MDA and level of cell apoptosis were improved, but SOD was reduced. However, in PTPRO knockout cells opposite results were found. TLR4 and NF-κB/p65 phosphorylation was significantly enhanced in PTPRO over-expressing cells, while significantly down-regulated in PTPRO knockout cells.
CONCLUSION: PTPRO plays ital roles in AS via promoting ox-LDL induced oxidative stress and cell apoptosis through TLR4/NF-κB pathway.
© 2017 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Atherosclerosis; Macrophage; Ox-LDL; Protein tyrosine phosphatase receptor type O

Mesh:

Substances:

Year:  2017        PMID: 28578349     DOI: 10.1159/000477596

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  12 in total

1.  Impact of medication on blood transcriptome reveals off-target regulations of beta-blockers.

Authors:  Michael Rode; Kolja Nenoff; Kerstin Wirkner; Katrin Horn; Andrej Teren; Ralf Regenthal; Markus Loeffler; Joachim Thiery; Achim Aigner; Janne Pott; Holger Kirsten; Markus Scholz
Journal:  PLoS One       Date:  2022-04-21       Impact factor: 3.240

2.  Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function.

Authors:  Xiaowen Yu; Xia Meng; Man Xu; Xuejuan Zhang; Yue Zhang; Guixia Ding; Songming Huang; Aihua Zhang; Zhanjun Jia
Journal:  EBioMedicine       Date:  2018-09-27       Impact factor: 8.143

3.  TRIF Regulates BIC/miR-155 via the ERK Signaling Pathway to Control the ox-LDL-Induced Macrophage Inflammatory Response.

Authors:  Yaxi Wu; Jinshan Ye; Ruiwei Guo; Xing Liang; Lixia Yang
Journal:  J Immunol Res       Date:  2018-06-07       Impact factor: 4.818

4.  Circulating Exosomal SOCS2-AS1 Acts as a Novel Biomarker in Predicting the Diagnosis of Coronary Artery Disease.

Authors:  Caihong Liang; Lulu Zhang; Xiaoqing Lian; Tiantian Zhu; Yuqing Zhang; Ning Gu
Journal:  Biomed Res Int       Date:  2020-04-09       Impact factor: 3.411

5.  The proatherosclerotic function of indoleamine 2, 3-dioxygenase 1 in the developmental stage of atherosclerosis.

Authors:  Heng Liang; Mantian Chen; Fangfei Qi; Lei Shi; Zhenzhen Duan; Ruoyu Yang; Jinchao He; Bin Lou; Yigang Li; Qing Yang
Journal:  Signal Transduct Target Ther       Date:  2019-07-19

6.  Virtual screening and network pharmacology-based synergistic mechanism identification of multiple components contained in Guanxin V against coronary artery disease.

Authors:  Bo Liang; Xiao-Xiao Zhang; Ning Gu
Journal:  BMC Complement Med Ther       Date:  2020-11-13

Review 7.  Natural Drugs as a Treatment Strategy for Cardiovascular Disease through the Regulation of Oxidative Stress.

Authors:  Xing Chang; Tian Zhang; Wenjin Zhang; Zhenyu Zhao; Jiahui Sun
Journal:  Oxid Med Cell Longev       Date:  2020-09-27       Impact factor: 6.543

8.  Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations.

Authors:  Anca Liliana Cismaru; Deborah Rudin; Luisa Ibañez; Evangelia Liakoni; Nicolas Bonadies; Reinhold Kreutz; Alfonso Carvajal; Maria Isabel Lucena; Javier Martin; Esther Sancho Ponce; Mariam Molokhia; Niclas Eriksson; Stephan Krähenbühl; Carlo R Largiadèr; Manuel Haschke; Pär Hallberg; Mia Wadelius; Ursula Amstutz
Journal:  Genes (Basel)       Date:  2020-10-29       Impact factor: 4.096

Review 9.  Regulatory Functions of Protein Tyrosine Phosphatase Receptor Type O in Immune Cells.

Authors:  Feiling Xie; Hongmei Dong; Hao Zhang
Journal:  Front Immunol       Date:  2021-11-22       Impact factor: 7.561

10.  Tanshinone IIA ameliorates non-alcoholic fatty liver disease through targeting peroxisome proliferator-activated receptor gamma and toll-like receptor 4.

Authors:  Lu Huang; Wei Ding; Ming-Qiang Wang; Zheng-Gen Wang; Hong-Hui Chen; Wen Chen; Qiong Yang; Ting-Na Lu; Qing Yang; Ji-Man He
Journal:  J Int Med Res       Date:  2019-08-05       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.